Potential Drugs and Chemotherapeutants for Marine Shrimp Production: Selection, Evaluation, and Approval Processes, Year 01
July 1, 1987
|Hawaii||$192,945||University of Arizona, John Controulis Ph.D., Inc., and University of Hawaii at Manoa||D.V. Lightner, R. Williams, and T. Bell|
- Define significant disease problems of penaeid shrimp larval rearing facilities, and in particular those disease which appear to be potentially treatable.
- Identify and test likely drugs and/or chemotherapeutants for the treatment of disorders or syndromes, previously defined as potentially treatable.
- In cooperation with an industry sponsor(s), obtain approval for the selected compound(s) from the appropriate Federal government agency.
- Perform studies that will identify and lead to the approval of one or more orally administered (via prepared feeds) antibacterial therapeutants.